01988nas a2200193   4500000000100000008004100001653003900042653002900081653002200110100001300132700001300145700001200158245005800170856020800228300001100436490000700447520132600454022001401780       2016                            d10aNeglected tropical diseases (NTDs)10aMass drug administration10aBiosocial aspects1 aParker M1 aPolman K1 aAllen T00aNeglected tropical diseases in biosocial perspective.  uhttp://journals.cambridge.org/action/displayFulltext?type=6&fid=10406565&jid=JBS&volumeId=48&issueId=S1&aid=10406564&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RA&fileId=S0021932016000274  aS1-S150 v483 a<p>The term 'neglected tropical diseases' (NTDs) points to the need for a biosocial perspective. Although 'diseases' are widely understood as biological phenomena, 'neglect' is inherently social. Social priorities, social relations and social behaviour profoundly influence the design, implementation and evaluation of control programmes. Yet, these dimensions of neglect are, themselves, neglected. Instead, emphasis is being placed on preventive chemotherapy - a technical, context-free approach which relies almost entirely on the mass distribution of drugs, at regular intervals, to populations living in endemic areas. This article reflects on the processes which have enabled an NTD 'brand' identity to emerge, and it comments on a disquieting disengagement with some of the more critical insights about the consequences of mass drug administration. Building on the work of biosocial scholars studying other aspects of health and disease, a more adequate, evidence-based approach is delineated. Developing such an approach is an iterative process, requiring on-going engagement with both biological and social insights as they emerge. Considerable theoretical, methodological and political challenges lie ahead, but it is essential they are overcome, if the sustainable control of NTDs is to become a reality.</p>
  a1469-7599